Approval · Notice of Compliance 1617 · 1999
BAYCOL: Notice of Compliance 1617
Issued December 22, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1617
- Date
- December 22, 1999
- Company
- Bayer Inc.Elkhart, Indiana, United States
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Lipid metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BAYCOL | 02241466 | Cancelled Post Market |
Medicinal ingredients
- CERIVASTATIN 0.4 MG per TAB